The Derma Co, one of the key skincare brands owned by Honasa Consumer, has crossed ₹1,000 crore in annualised net sales, marking a major milestone in the company’s strategy of building multiple large beauty and personal care brands. Honasa founder and CEO Varun Alagh said the achievement makes Honasa the only Indian FMCG company to have built two ₹1,000-crore brands in the last decade, following Mamaearth’s earlier milestone.
The development is significant because The Derma Co has reached the threshold several years after Mamaearth, demonstrating Honasa’s attempt to replicate the playbook it used to scale its flagship brand. The company has increasingly positioned itself as a “house of brands”, with The Derma Co, Aqualogica, BBlunt, Dr Sheth’s and other brands complementing Mamaearth. The latest milestone also comes as Honasa reports stronger growth and profitability, giving its multi-brand strategy greater importance for the company’s next phase.
The Derma Co Crosses ₹1,000 Crore Annualised Sales
The Derma Co has crossed ₹1,000 crore in annualised net sales value (NSV), according to Honasa founder Varun Alagh.
Annualised sales are different from reported annual revenue. An annualised run rate takes the brand’s current sales pace and projects it over a full year.
That distinction is important because the ₹1,000-crore figure does not necessarily mean The Derma Co generated exactly ₹1,000 crore of reported revenue during the latest financial year.
| The Derma Co Milestone | Latest Figure |
|---|---|
| Annualised net sales | ₹1,000+ Cr |
| Brand category | Skincare |
| Parent company | Honasa Consumer |
| Founder | Varun Alagh |
| Launch | 2020 |
| Position in Honasa portfolio | Second ₹1,000-crore brand |
The milestone nevertheless establishes The Derma Co as a major Indian beauty brand by scale.
Honasa Now Has Two ₹1,000-Crore Brands
The achievement gives Honasa two brands that have crossed the ₹1,000-crore annualised sales mark.
Mamaearth was the first.
The Derma Co is now the second.
According to Alagh, this makes Honasa the only Indian FMCG company to have built two ₹1,000-crore brands in the last decade.
The claim highlights the difficulty of building large consumer brands in India.
Honasa’s ₹1,000-Crore Brand Journey
2016
Mamaearth launched
↓
2022
Mamaearth crosses ₹1,000 crore annual revenue milestone
↓
2023
Honasa Consumer lists on Indian stock exchanges
↓
2026
The Derma Co crosses ₹1,000 crore annualised NSV
↓
Result
Two ₹1,000-crore brands under one Indian consumer company
Mamaearth had previously been described by the company as the fastest-growing beauty and personal care brand in India to reach ₹1,000 crore in annual revenue. :contentReference[oaicite:0]{index=0}
The Derma Co Was Built Around Active-Ingredient Skincare
The Derma Co was created around a different proposition from Mamaearth.
While Mamaearth initially built its identity around natural and toxin-free personal care products, The Derma Co focused on active ingredients and problem-solving skincare.
Its portfolio includes products built around ingredients such as salicylic acid, niacinamide, hyaluronic acid and other commonly used skincare actives.
That positioning helped the brand target consumers looking for more treatment-oriented skincare products.
Honasa had identified the growing consumer interest in active ingredients as an important opportunity and subsequently expanded The Derma Co across skincare categories.
From D2C Brand to Mass-Market Skincare Player
The Derma Co began as a digital-first brand.
Its early growth was closely connected to e-commerce and direct-to-consumer channels, allowing the company to launch products quickly and collect consumer feedback.
The brand has since expanded beyond online marketplaces.
Honasa’s broader distribution strategy now includes general trade, modern trade and e-commerce.
The transition is important because reaching ₹1,000 crore in annualised sales requires considerably broader distribution than a niche online-only brand.
The Derma Co’s Growth Engine
Digital-first
→ Online discovery and customer acquisition
Product innovation
→ Active-ingredient focused products
Omnichannel expansion
→ E-commerce + modern trade + general trade
Category expansion
→ Sunscreen + face care + hair care + other skincare
Scale
→ ₹1,000+ crore annualised NSV
The strategy is similar to the broader transformation of Honasa from a D2C startup into an omnichannel FMCG company.
Why the ₹1,000-Crore Milestone Matters
Crossing ₹1,000 crore is an important scale milestone in India’s consumer industry.
At this level, a brand has a large enough revenue base to support significantly wider distribution, marketing and product development.
It can also generate stronger bargaining power with retailers and distributors.
For Honasa, the milestone is even more important because it demonstrates that the company’s brand-building model can potentially be repeated.
The company is no longer dependent on Mamaearth alone to generate meaningful scale.
The Derma Co Is Growing Alongside Mamaearth
Honasa’s latest financial performance suggests that its younger brands are becoming increasingly important.
In Q4 FY26, the company said its younger brands, including The Derma Co, Aqualogica, BBlunt and Dr Sheth’s, were growing at more than 40% collectively.
Mamaearth, meanwhile, was continuing to grow at a high-teens rate. :contentReference[oaicite:1]{index=1}
This creates an important portfolio dynamic.
Mamaearth provides scale and a large existing consumer base, while younger brands provide faster growth.
| Honasa Brand Group | Recent Growth / Position |
|---|---|
| Mamaearth | ₹1,000+ crore brand; high-teens growth |
| The Derma Co | ₹1,000+ crore annualised NSV |
| Aqualogica | Younger high-growth brand |
| BBlunt | Younger portfolio brand |
| Dr Sheth’s | Premium skincare brand |
| Reginald Men | Fast-growing men’s grooming brand |
The strategy allows Honasa to pursue growth at different stages of the consumer-brand lifecycle.
The Company Has Been Preparing The Derma Co for ₹1,000 Crore
The latest milestone is not entirely unexpected.
Honasa had previously identified The Derma Co as the next major brand capable of reaching ₹1,000 crore.
In 2024, the company said it expected The Derma Co to reach a ₹1,000-crore annual revenue run rate within three to five years.
At the time, Honasa also expected Aqualogica and Dr Sheth’s to eventually reach ₹500 crore in annual revenue run rates, while BBlunt was targeted at ₹250 crore. :contentReference[oaicite:2]{index=2}
The Derma Co has therefore reached the milestone toward the earlier end of the company’s stated timeframe.
Honasa Is Trying to Replicate Its Mamaearth Playbook
The company’s strategy for The Derma Co reflects lessons learned from Mamaearth.
Honasa has said that it identified the active-ingredient trend early and used its experience from building Mamaearth to scale The Derma Co.
That includes product innovation, digital marketing, distribution expansion and brand-building.
In a May 2026 earnings call, Alagh described The Derma Co as the second brand started by Honasa and highlighted the company’s ambition to demonstrate that its brand-building playbook could be replicated. :contentReference[oaicite:3]{index=3}
The ₹1,000-crore milestone provides evidence that the approach can work beyond the company’s flagship brand.
Honasa’s Financial Performance Is Also Improving
The Derma Co milestone comes at an important time for Honasa.
The company reported its highest-ever quarterly revenue and profit in Q1 FY27.
Revenue reached about ₹785 crore, while EBITDA increased to ₹110 crore and net profit reached ₹90 crore, according to recent company results. :contentReference[oaicite:4]{index=4}
Honasa Q1 FY27 Snapshot
Revenue: ₹785 Cr
EBITDA: ₹110 Cr
EBITDA margin: 14.1%
Profit after tax: ₹90 Cr
PAT margin: 11.5%
The improvement in profitability gives Honasa more financial flexibility to continue investing in its growing brands.
The Derma Co Is Part of a Larger Portfolio Strategy
Honasa’s long-term objective is not to operate only two large brands.
The company has built a portfolio covering multiple categories and consumer segments.
Mamaearth focuses on broad beauty and personal care, while The Derma Co has a stronger skincare and active-ingredient positioning.
Aqualogica operates in skincare and hydration, Dr Sheth’s targets premium skincare, BBlunt focuses on haircare and Reginald Men addresses men’s grooming.
This gives Honasa multiple opportunities to build brands without forcing every product into the same positioning.
The Portfolio Approach Reduces Dependence on Mamaearth
The importance of The Derma Co can also be understood through Honasa’s history.
Mamaearth remains the company’s flagship brand, but relying too heavily on one brand creates concentration risk.
If consumer interest in a particular product category weakens, the company’s overall growth could slow.
A successful multi-brand portfolio provides a potential buffer.
If one brand grows more slowly, another can potentially offset some of the weakness.
The Derma Co reaching ₹1,000 crore therefore represents more than a standalone brand milestone. It strengthens Honasa’s overall portfolio.
India’s Skincare Market Is Becoming More Competitive
The Derma Co’s growth comes as India’s skincare market becomes increasingly crowded.
Traditional FMCG companies, pharmacy-led brands, specialist dermatology brands and digital-first startups are all competing for consumers.
Consumers also have access to a much wider range of products through e-commerce platforms.
This creates both opportunities and challenges.
A brand can scale quickly through digital distribution, but maintaining growth becomes harder as competition increases.
The Derma Co will therefore need to continue investing in product innovation, distribution and brand awareness.
Distribution Is Becoming a Critical Growth Lever
The next stage of growth is likely to depend increasingly on physical distribution.
Digital channels helped The Derma Co build its initial consumer base, but mass-market scale requires access to physical retail.
Honasa said its focus categories were gaining traction across general trade, e-commerce and modern trade, with more than 10,000 outlets billed directly through distributors and around 120,000 modern-trade outlets reached in FY26. :contentReference[oaicite:5]{index=5}
This expanding distribution network gives The Derma Co more opportunities to reach consumers who do not primarily shop for skincare online.
The Challenge Is Sustaining Growth After ₹1,000 Crore
Reaching ₹1,000 crore is a major milestone, but maintaining rapid growth at that scale is more difficult.
A brand can achieve fast growth when its revenue base is relatively small.
Once sales cross ₹1,000 crore, adding another ₹500 crore requires significantly more absolute revenue than it did earlier.
The company will therefore need to expand into new product categories, increase penetration in existing categories and attract new consumers.
The ability to maintain growth while protecting margins will be particularly important.
Profitability Will Matter More
Honasa’s recent turnaround has placed greater emphasis on profitability.
The company reported a sharp improvement in EBITDA and net profit in Q1 FY27.
That makes the economics of The Derma Co increasingly important.
Rapid sales growth is valuable, but a ₹1,000-crore brand that requires excessive advertising and discounts to maintain its momentum may not generate attractive long-term returns.
Honasa will therefore need to demonstrate that its brands can grow while maintaining disciplined marketing and operating expenses.
Key Numbers at a Glance
₹1,000+ Cr
The Derma Co’s annualised net sales
2
₹1,000-crore brands built by Honasa
₹1,000+ Cr
Mamaearth’s annual revenue scale
40%+
Collective recent growth of Honasa’s younger brands
₹785 Cr
Honasa Q1 FY27 revenue
₹110 Cr
Q1 FY27 EBITDA
₹90 Cr
Q1 FY27 net profit
14.1%
Q1 FY27 EBITDA margin
10,000+
Directly billed outlets through distributors in FY26
~120,000
Modern-trade outlets reached in FY26
What The Derma Co’s Milestone Means for Honasa
The Derma Co crossing ₹1,000 crore in annualised net sales is a significant validation of Honasa’s house-of-brands strategy.
The company has shown that it can build a large consumer brand outside its original flagship.
That gives Honasa a stronger foundation for its next phase of expansion.
The bigger opportunity is now to repeat the process with brands such as Aqualogica, Dr Sheth’s, BBlunt and its newer businesses.
What It Means for India’s FMCG Market
The achievement also highlights the growing importance of new-age consumer companies in India’s FMCG industry.
Traditional FMCG companies have historically dominated the market through large distribution networks and decades-old brands.
Digital-first companies have changed the path to building consumer brands.
They can identify consumer trends, launch products quickly, use digital marketing to acquire customers and subsequently expand into physical retail.
Honasa’s journey from Mamaearth to The Derma Co shows how that model can potentially produce multiple large brands under one corporate platform.
Looking Ahead
The Derma Co crossing ₹1,000 crore in annualised net sales marks a major milestone for Honasa Consumer and its house-of-brands strategy. According to founder Varun Alagh, the achievement makes Honasa the only Indian FMCG company to have built two ₹1,000-crore brands in the last decade, following Mamaearth. The milestone is particularly important because The Derma Co was built after Mamaearth and demonstrates that Honasa has been able to replicate elements of its brand-building strategy across a different skincare proposition.
The next challenge will be sustaining growth as The Derma Co moves into a much larger revenue bracket. Honasa will need to expand distribution, continue launching relevant products and maintain profitability while competing against established FMCG companies and specialist skincare brands. With Mamaearth already at ₹1,000-crore scale and The Derma Co now reaching the same threshold, the company’s ability to turn Aqualogica, Dr Sheth’s, BBlunt and other younger brands into large businesses will determine whether its multi-brand strategy can create a broader consumer powerhouse.
Get the day’s top stories in your inbox
One concise email. No spam, unsubscribe anytime.
